4//SEC Filing
Hemrajani Rekha 4
Accession 0001209191-22-041607
CIK 0001287098other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 4:03 PM ET
Size
5.5 KB
Accession
0001209191-22-041607
Insider Transaction Report
Form 4
MAXCYTE, INC.MXCT
Hemrajani Rekha
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-29+26,900→ 26,900 totalExercise: $4.82Exp: 2032-06-28→ Common Stock (26,900 underlying)
Footnotes (1)
- [F1]This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date.
Documents
Issuer
MAXCYTE, INC.
CIK 0001287098
Entity typeother
Related Parties
1- filerCIK 0001771213
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 4:03 PM ET
- Size
- 5.5 KB